Company Reports

Ypsomed is a manufacturer of drug delivery devices for self-injection, specializing in injection pens, autoinjectors, and wearable injectors. Its devices deliver a broad range of liquid therapeutics, from established small-molecule drugs such as insulin to large-molecule biologics and the emerging class of GLP-1 receptor agonists for weight management and metabolic disease.

We are initiating coverage of Ypsomed, a manufacturer of self-injection devices, including pens, autoinjectors, and wearable injectors. It recently sold its diabetes care division to focus solely on injection devices, targeting a market with rising GLP-1 demand.

Ypsomed is a manufacturer of drug delivery devices for self-injection, specializing in injection pens, autoinjectors, and wearable injectors. Its devices are used to administer a broad range of liquid therapeutics, from established small-molecule drugs such as insulin to large-molecule biologics and the emerging class of GLP-1 receptor agonists for weight management and metabolic disease.